AC
VNDA icon

Amici Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

Amici Capital’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,000
Closed -$832K – 94
2016
Q3 		$832K Hold
50,000
– – 0.22% 67
2016
Q2 		$560K Hold
50,000
– – 0.11% 94
2016
Q1 		$418K Buy
+50,000
New +$410K 0.05% 95

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Amici Capital's VNDA Position: Q4 2016 in Review

Amici Capital sold out of Vanda Pharmaceuticals (VNDA) in Q4 2016, closing a stake of 50,000 shares — an estimated $832K sold.

Amici Capital first reported a position in VNDA in Q1 2016 and held it in 3 quarters. The position peaked at $832K in Q3 2016. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • Amici Capital reported no remaining Vanda Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Amici Capital sold 50,000 Vanda Pharmaceuticals shares in Q4 2016, an estimated $832K.
  • Amici Capital first reported a position in Vanda Pharmaceuticals in Q1 2016 and held it in 3 quarters.
  • Amici Capital's Vanda Pharmaceuticals position peaked at $832K in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on Amici Capital's 13F filing for Q4 2016, filed 14 Feb 2017.